Nervo (NYSE:NVRO) this week announced it appointed Kevin Thornal as CEO and president, effective April 24. Thornal succeeds D. Keith Grossman, who is retiring, also effective April 24. Grossman will be appointed to serve as executive chair of the company. “On behalf of the board and our entire company, I am excited to welcome Kevin […]
Fresenius Kabi recall of Ivenix infusion systems in Class I
The FDA this week said the Fresenius Kabi recall of some Ivenix infusion systems is Class I, the most serious kind. Fresenius Kabi is recalling some Ivenix infusion systems due to a leak in the system that allows fluid to enter the administration set loading area near the air detector. The leak could damage the […]
Ra Medical Systems CEO resigns
Ra Medical Systems (NYSE:RMED) CEO Will McGuire this week announced his resignation from the company due to personal reasons. The resignation will take effect on April 28. He will also resign from his position on the board of directors of the electrophysiology procedures tech company. Ra Medical’s board of directors has established a committee for […]
FDA clears Neuspera Medical peripheral nerve stim
Neuspera Medical this week announced its ultra-miniaturized neurostimulator system received FDA clearance. The Neuspera system is a micro-implant that delivers neurostimulation therapy through a wireless platform, including a wearable transmitter and iPad-based clinician programmer. The company designed the system to provide peripheral nerve stimulation (PNS) in an ultra-miniaturized option to allow for a better patient […]
Fresenius Kabi wins Vizient contract for Ivenix infusion system
Fresenius Kabi this week announced its Ivenix infusion system was awarded an Innovative Technology contract from Vizient. Vizient members include more than half of all acute care hospitals in the U.S., and the Innovative Technology contracts are recommended after review and interaction with products submitted through the organization’s program. The contract sets terms for hospitals […]
Cardiovascular Systems completes enrollment in Eclipse clinical trial
Cardiovascular Systems this week announced it completed enrollment in its Eclipse coronary trial. The company enrolled 2,000 patients with severely calcified coronary lesions in the prospective, multicenter, randomized clinical trial. Half of the participants received orbital atherectomy prior to drug-eluting stent implantation, and the other hand received conventional angioplasty, including specialty balloons and DES implantation. […]
Boston Scientific completes Apollo Endosurgery acquisition
Boston Scientific today announced it completed the acquisition of Apollo Endosurgery. The acquisition was announced in November and had an enterprise value of approximately $615 million. Apollo Endosurgery’s product portfolio includes devices used during endoluminal surgery (ELS) procedures. The ELS procedures close gastrointestinal defects, manage gastrointestinal complications and aid in weight loss. ELS procedures are […]
Enovis to acquire Novastep to expand foot and ankle portfolio
Enovis (NYSE: ENOV) today announced it would acquire Novastep and its foot and ankle minimally invasive surgical (MIS) platform for an undisclosed amount. The transaction is subject to customary conditions and regulatory approvals. It is expected to close in the second quarter of 2023. Novastep generates about $20 million in annual revenue. Its MIS platform, […]
Here’s MassDevice’s medtech layoffs tips line
Loading…
NuVasive expands indications of limb lengthening system to include pediatrics
NuVasive this week announced it received FDA 510(k) clearance for the use of its Precice all-internal limb lengthening solution for pediatric patients. Precice is a magnetically adjustable technology that uses an external remote to non-invasively lengthen implants. The system’s nail has been implanted more than 15,000 times by more than 2,000 surgeons. “Precice has over […]
InspireMD names Andrea Tommasoli as chief operating officer
InspireMD (NYSE:NSPR) this week announced it appointed Andrea Tommasoli as chief operating officer. Tommasoli was previously the company’s senior VP of global sales and marketing since November 2020. Prior to joining InspireMD, Tommasoli was most recently the senior sales director of indirect markets at Integra Lifesciences. “Andrea has been instrumental in expanding the footprint of CGuard […]